Compare
Brookfield Wealth Solutions Ltd. vs Oscar Health, Inc. vs Assurant, Inc. vs Renaissancere Holdings Ltd
| Latest fiscal year | Brookfield Wealth Solutions Ltd. BNT | Oscar Health, Inc. OSCR | Assurant, Inc. AIZ | Renaissancere Holdings Ltd RNR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $11.63B | $11.70B | $12.81B | $12.85B |
| Revenue growth (YoY) | -17.5% | +27.5% | +7.9% | +9.9% |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | n/a | -3.4% | n/a | n/a |
| Net margin | 7.4% | -3.8% | 6.8% | 20.9% |
| Net income | $863.00M | -$443.15M | $872.70M | $2.68B |
| EPS (Diluted) | n/a | -$1.69 | $16.93 | $56.03 |
| Operating cash flow | $2.61B | $1.09B | $1.83B | $3.69B |
| Free cash flow | $2.54B | $1.06B | $1.60B | n/a |
| Cash & equivalents | $13.01B | $2.77B | $1.83B | $1.73B |
| Total assets | $157.18B | $6.33B | $36.29B | $53.80B |
| Total liabilities | $139.26B | $5.34B | $30.42B | $34.59B |
| Shareholders' equity | $17.92B | $980.74M | $5.87B | $11.61B |
| Return on year-end equity | 4.8% | -45.2% | 14.9% | 23.1% |
| Shares outstanding | n/a | n/a | 49.79M | 43.96M |
Revenue, most recent five fiscal years
| Fiscal year | Brookfield Wealth Solutions Ltd. | Oscar Health, Inc. | Assurant, Inc. | Renaissancere Holdings Ltd |
|---|---|---|---|---|
| Latest | $11.63B Ended 2025-12-31 | $11.70B Ended 2025-12-31 | $12.81B Ended 2025-12-31 | $12.85B Ended 2025-12-31 |
| 1 year earlier | $14.10B Ended 2024-12-31 | $9.18B Ended 2024-12-31 | $11.88B Ended 2024-12-31 | $11.70B Ended 2024-12-31 |
| 2 years earlier | $6.91B Ended 2023-12-31 | $5.86B Ended 2023-12-31 | $11.13B Ended 2023-12-31 | $9.13B Ended 2023-12-31 |
| 3 years earlier | $4.41B Ended 2022-12-31 | $3.96B Ended 2022-12-31 | $10.19B Ended 2022-12-31 | $5.06B Ended 2022-12-31 |
| 4 years earlier | $1.04B Ended 2021-12-31 | $1.84B Ended 2021-12-31 | $10.19B Ended 2021-12-31 | $5.28B Ended 2021-12-31 |